Sharda Cropchem
Market cap ₹6,304 Cr
- P/E
- 9.79
- Day range
- ₹691.60 – ₹712.05
- 52-week range
- ₹622.50 – ₹1,297.00
- Volume
- 1.00 L
- Open
- ₹705.00
- Prev close
- ₹709.15
Latest results · Q2 FY27(consolidated)Revenue ₹1,052 Cr+13.2%Profit ₹92 Cr+23.4%Margin 8.7%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
SHARDACROP in NSE indices and F&O
Research profile
Composite 51 / 100Factor percentiles
Derived metrics
- Earn. yield
- 10.2%
- Graham no.
- ₹748.59
- vs Graham
- +7.1%
- ROE ÷ P/B
- 12.1%
- 12-1 mom.
- -6.1%
- Return / vol
- -0.20
- Magic Formula
- #16
- FCF yield
- 2.5%
Appears in 15 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Sharda CropchemSHARDACROP | ₹6,304 Cr | 9.79 | 2.00 | 24.2% | 30.0% | 16.0% | 0.01 | +13.2% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 2h agoHeadlines about Sharda Cropchem from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 10.1
- Price / Book
- 1.94
- ROE (FY26)
- 24.2%
- ROCE (latest year)
- 30%
- Dividend yield
- 2.08%
Moving averages (NSE)
- 20-day
- ₹684.61
- Price above
- 50-day
- ₹718.81
- Price below
- 200-day
- ₹904.54
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 632 | 1,312 | 785 | 777 | 929 | 1,829 | 985 | 929 | 1,289 | 2,065 | 1,074 | 1,052 |
| YoY Sales growth | -38 | -11 | — | — | — | — | — | — | — | — | — | — |
| Expenses | 563 | 1,057 | 708 | 687 | 815 | 1,525 | 770 | 796 | 1,048 | 1,578 | 888 | 888 |
| Operating Profit | 69 | 255 | 77 | 90 | 115 | 303 | 215 | 133 | 241 | 487 | 186 | 164 |
| OPM % | 11% | 19% | 10% | 12% | 12% | 17% | 22% | 14% | 19% | 24% | 17% | 16% |
| Other Income | 12 | -2 | 19 | 25 | 1 | 25 | 32 | 29 | 21 | 22 | 35 | 45 |
| Interest | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 |
| Depreciation | 69 | 54 | 65 | 69 | 69 | 72 | 78 | 76 | 83 | 87 | 100 | 100 |
| Profit before tax | 12 | 198 | 31 | 46 | 46 | 256 | 169 | 86 | 179 | 422 | 118 | 107 |
| Tax % | 62% | 28% | 11% | 7% | 32% | 20% | 16% | 13% | 19% | 24% | 26% | 15% |
| Net Profit | 5 | 143 | 27 | 42 | 31 | 204 | 143 | 74 | 145 | 319 | 88 | 92 |
| EPS in Rs | ₹0.51 | ₹15.90 | ₹3.02 | ₹4.70 | ₹3.45 | ₹22.56 | ₹15.83 | ₹8.24 | ₹16.09 | ₹35.32 | ₹9.76 | ₹10.17 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-11 days since Mar 2021
+4 days since Mar 2021
-18 days since Mar 2021
+11 days since Mar 2021
+8 days since Mar 2021
Strengths, risks & growth
Sharda Cropchem is principally engaged in export of agrochemicals (technical grade and formulations) and non-agro products such as conveyor belts, rubber belts/sheets, dyes and dye intermediates to various countries across the world.
Strengths
- Company is almost debt free.
- Company has delivered good profit growth of 23.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 43.8%
Risks
- Company has a low return on equity of 13.2% over last 3 years.
- Company has high debtors of 166 days.
Compounded Sales Growth
- 10 Years
- +16%
- 5 Years
- +17%
- 3 Years
- +9%
- TTM
- +17%
Compounded Profit Growth
- 10 Years
- +14%
- 5 Years
- +24%
- 3 Years
- +26%
- TTM
- +42%
Stock Price CAGR
- 10 Years
- +6%
- 5 Years
- +17%
- 3 Years
- +19%
- 1 Year
- -9%
Return on Equity
- 10 Years
- +16%
- 5 Years
- +15%
- 3 Years
- +13%
- Last Year
- +23%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 74.82% | 74.82% | 74.82% | 74.82% | 0.00 pp |
| FII | 4.20% | 4.60% | 3.12% | 3.27% | +0.15 pp |
| DII | 9.95% | 9.70% | 9.18% | 9.22% | +0.04 pp |
| Public | 11.02% | 10.88% | 12.88% | 12.69% | -0.19 pp |
Filed with NSE for Sept 2026: promoters 74.82%, public 25.18%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 8.91% (+0.03 pp)- Promoters74.8%
- Foreign institutions3.3%
- Mutual funds8.9%
- Insurance0.0%
- Other domestic institutions0.3%
- Retail8.1%
- Others4.6%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| HDFC Small Cap Fund | 5.68% | 0.93% | -0.14 pp |
| DSP Small Cap Fund | 1.39% | 0.44% | -0.10 pp |
| HDFC Aggressive Hybrid Fund | 1.04% | 0.32% | -0.05 pp |
| Bandhan Balanced Advantage Fund | 0.13% | 0.36% | -0.07 pp |
| Bandhan Business Cycle Fund | 0.07% | 0.48% | +0.05 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Avg
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 47.3%
- Downside volatility
- 46.6%
- Worst 5% of days
- 4.2%
- Average of that tail
- 7.1%
- Max drawdown (1Y)
- 49.8%
- Below its peak
- 44.4%
Against the market
- Beta vs Nifty 50
- 1.05
- Correlation
- 0.30
- Relative strength (3M)
- -15.1%
- ATR (14)
- 3.6%
Return
- Return 1M
- -3.7%
- Return 3M
- -11.2%
- Return 6M
- -22.5%
- Return 1Y
- -9.5%
- vs 200-day average
- -22.8%
Momentum
- RSI (14)
- 48.4
- MACD histogram
- 5.98
- Stochastic %K
- 44.2
- ADX (14)
- 22.7
- +DI / −DI
- 23.3 / 22.8
- Money flow index
- 43.2
Participation
- Delivery (20d avg)
- 45.3%
- vs its 60-day baseline
- -3.9 pts
- Volume vs 20-day
- -0.5σ
- Close vs day's VWAP
- -0.4%
- 52-week position
- 11 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹158 Cr
- FCF yield
- 2.5%
- Cash conversion
- 0.96
- Accruals ratio
- 0.004
- Net debt
- -₹275 Cr
- Net debt / equity
- -0.08
- EV / sales
- 1.12
- Capex intensity
- 9.4%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹9.00
Dividend - Rs 9 Per Share
7 Aug 2026ex-date - dividend₹6.00
Interim Dividend - Rs 6 Per Share
6 Feb 2026ex-date - dividend₹6.00
Dividend - Rs 6 Per Share
7 Aug 2025ex-date - dividend₹3.00
Interim Dividend - Rs 3 Per Share
6 Feb 2025ex-date - otherNot available — not reported in this filing
Annual General Meeting
2 Aug 2024ex-date - dividend₹3.00
Dividend - Rs 3 Per Share
2 Aug 2024ex-date - dividend₹3.00
Dividend - Rs 3 Per Share
1 Aug 2023ex-date - otherNot available — not reported in this filing
Annual General Meeting
1 Aug 2023ex-date - dividend₹3.00
Interim Dividend - Rs 3 Per Share
7 Feb 2023ex-date - dividend₹3.00
Dividend - Rs 3 Per Share
25 Jul 2022ex-date - dividend₹3.00
Interim Dividend - Rs 3 Per Share
2 Feb 2022ex-date - dividend₹3.00
Dividend - Rs 3 Per Share
20 Jul 2021ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share
9 Nov 2020ex-date - otherNot available — not reported in this filing
Annual General Meeting
21 Sept 2020ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share
5 Mar 2020ex-date - dividend₹2.00
Interim Dividend Rs 2 Per Share
31 Jan 2020ex-date - dividend₹2.00
Annual General Meeting/Dividend - Rs 2 Per Share
16 Aug 2019ex-date - dividend₹2.00
Interim Dividend - Rs 2 Per Share
4 Feb 2019ex-date - dividend₹2.00
Annual General Meeting/Dividend Rs 2/- Per Share
20 Aug 2018ex-date - dividend₹2.00
Interim Dividend - Rs 2/- Per Share
6 Nov 2017ex-date
Company announcements
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026
This is to inform that the trading window will be closed from 1st October, 2026 till 48 hours after the un-audited financial results are approved by the Board of Directors. The date of ....
Intimation of Schedule of Analyst / Institutional Investor Meeting
Voting Results for 23rd Annual General Meeting of the Company
Outcome of the 23rd Annual General Meeting of the Company
Newspaper Advertisement in relation to transfer of dividend and equity shares of the company to IEPF Authority.
Earnings Call Transcript of the conference call held on 30th July, 2026
Audio Recording of Earnings for Q1 FY 2026-27.
Newspaper Publication of Unaudited financial results for the quarter ended 30th June, 2026.
Media Release on Unaudited Financial Results for the quarter ended 30th June, 2026
Investor Presentation for quarter ended 30th June, 2026
To consider and approve Unaudited Financial Results for quarter ended 30th June, 2026
Outcome of Board Meeting to consider and approve Unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2026
The Company has scheduled a Conference call for analyst and investors on Thursday, 30th July, 2026 at 03.30 P.M. IST.
Sharda Cropchem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve Unaudited Standalone & Consolidated ....
Filed with BSE (scrip 538666); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
- Jul 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 23 Feb from crisil
- Rating update · 10 Mar 2025 from crisil
- Rating update · 13 Feb 2024 from crisil
- Rating update · 21 Aug 2023 from crisil
- Rating update · 5 Jul 2022 from crisil
- Rating update · 14 Jul 2021 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 31 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Sharda Cropchem: common questions
Answered from the figures on this page.